180 likes | 641 Vues
Interim Analysis in Clinical Trials: A Bayesian Approach in the Regulatory Setting Telba Z. Irony, Ph.D. and Gene Pennello, Ph.D . Division of Biostatistics Office of Surveillance and Biometrics Center for Devices and Radiological Health, FDA
E N D
Interim Analysis in Clinical Trials: A Bayesian Approach in the Regulatory Setting Telba Z. Irony, Ph.D. and Gene Pennello, Ph.D. Division of Biostatistics Office of Surveillance and Biometrics Center for Devices and Radiological Health, FDA No official support or endorsement by the Food and Drug Administration of this presentation is intended or should be inferred.